Comparison · NCT00717041-e320f201
Depressed in the ED vs Cognitively Impaired in the ED: Depression and Cognitive Impairment at 2 Weeks
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Depressed in the ED vs Cognitively Impaired in the ED: Depression and Cognitive Impairment at 2 Weeks. Trial comparisons, record NCT00717041-e320f201. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00717041-e320f201
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0336 | 0.0232 | 0.0485 | wilson | |
| Risk in group 2 | 0.00619 | 0.00265 | 0.0144 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0274 | 0.0142 | 0.0427 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 5.43 | 2.1 | 14 | log | |
| Odds ratio, group 1 over group 2 | 5.59 | 2.14 | 14.6 | log | |
| Number needed to treat, for one more participant with the outcome on Depressed in the ED than on Cognitively Impaired in the ED | 36.4 | 23.4 | 70.6 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Depressed in the ED | Patients who present to the ED who test positive for depression | 27 | 803 | OG000 |
| Group 2 | Cognitively Impaired in the ED | Patients presenting to the ED who have cognitive impairment | 5 | 808 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Depression and Cognitive Impairment at 2 Weeks
- Description
- For the individuals who are able to be contacted in 2 weeks, how many still test positive for depression and cognitive impairment.
- Time frame
- 2 weeks
- Population
Source ClinicalTrials.gov
Trial
- Title
- Epidemiology of Depression, Anxiety, and Cognitive Impairment
- NCT number
- NCT00717041
- Phases
- Conditions
- Depression, Anxiety, Cognitive Impairment
- Interventions
- Lead sponsor
- University of Rochester
- Results first posted
- 2015-06-15
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00717041?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00717041-e320f201